Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future

Area of Science:

• Immunology
• Pharmacology
• Infectious Diseases

Background:

• The COVID-19 pandemic caused millions of deaths globally.
• Vaccine development for SARS-CoV-2 was successful, but effective therapies remain elusive.
• Repurposed drugs showed limited efficacy in large-scale clinical trials for COVID-19 treatment.

Purpose of the Study:

• To review the role of immunomodulation in COVID-19 treatment.
• To discuss the pathophysiology of SARS-CoV-2 infection, emphasizing hyperinflammation and immune dysregulation.
• To propose novel immunologic targets for future COVID-19 therapeutic strategies.

Main Methods:

• Literature review of existing data on immunomodulation in COVID-19.
• Analysis of the immunological mechanisms underlying SARS-CoV-2-induced organ damage.
• Identification and proposal of new immunologic targets for pharmacological intervention.

Main Results:

• Hyperinflammation and immune dysregulation are key drivers of multiorgan damage in COVID-19.
• Existing therapeutic strategies targeting inflammation have shown mixed results.
• Immunomodulatory approaches hold significant potential for managing severe COVID-19.

Conclusions:

• Immunomodulation represents a promising avenue for COVID-19 pharmacological treatment.
• Further research into novel immunologic targets is crucial for developing effective therapies.
• Targeting immune responses could mitigate the severe consequences of SARS-CoV-2 infection.